My Cart

Human STEAP1 Full Length Protein, Twin-Strep,His Tag (Nanodisc)

Customer Reviews
Cat. No. / Size
Price
Qty
ST1-H5286-20ug
$1440.00
ST1-H5286-100ug
$5355.00
ST1-H5286-500ug
$12920.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Application

    1. Cell based assay (FACS or functional assay)
    2. Affinity testing (SPR / BLI)
    3. Screening (ELISA)
  • Synonyms

    STEAP1, PRSS24, STEAP

  • Source

    Nanodisc Human STEAP1 Full Length Protein, Twin-Strep,His Tag (ST1-H5286) is expressed from human 293 cells (HEK293). It contains AA Glu 2 - Leu 339 (Accession # Q9UHE8-1).

    Predicted N-terminus: Met

    Request for sequence
  • Molecular Characterization

    STEAP1 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a twin strep tag at the N-terminus and a polyhistidine tag at the C-terminus.

    The protein has a calculated MW of 44.7 kDa.

    *The isotype control of empty/mock nanodisc (Cat. No. APO-H51H3) is sold separately and not included in protein, you can follow the link for product information.

    1. Structure

      Nanodisc membrane protein is wrapped by a synthetic phospholipid bilayer membrane structure, composed of membrane scaffold proteins (MSPs) and phospholipids.

    2. Synthesis Process

      Nanodisc reconstitution is a self-assembly process that starts from purified, detergent-solubilized membrane proteins and reconstitutes them into synthetic phospholipid bilayers stabilized by MSP1D1 membrane scaffold protein. This creates a stable, detergent-free environment that preserves native conformation and biological activity, with excellent homogeneity and full compatibility with cell-based assays such as FACS and binding assays in antibody discovery and screening (ELISA),etc.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Supplied as 0.2 μm filtered solution in 20 mM HEPES, 150 mM NaCl, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Shipping and Storage

    This product is supplied and shipped on dry ice.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. The product MUST be stored at -70°C or lower upon receipt;
    2. -70°C for 3 months under sterile conditions.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Bioactivity-ELISA

     STEAP1 ELISA

    Immobilized Human STEAP1 Full Length Protein, Twin-Strep,His Tag (Cat. No. ST1-H5286) at 5 μg/mL (100 μL/well) on a Nickel Coated plate (Cat. No. SP-19) can bind Vandortuzumab biosimilar with a linear range of 0.005-0.156 μg/mL (QC tested).

    Protocol
  • Bioactivity-SPR

     STEAP1 SPR

    Monoclonal Anti-STEAP1 Antibody, Human IgG1 captured on Protein A Chip can bind Human STEAP1 Full Length Protein, Twin-Strep,His Tag (Cat. No. ST1-H5286) with an affinity constant of 8.04 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

    Protocol
  • Bioactivity-FACS

     STEAP1 FACS

    Non-specificity of Human STEAP1 Protein, Twin-Strep, His Tag (Nanodisc) (Cat. No. ST1-H5286) binding to CD3+T cells present in human PBMC. Human PBMCs were simultaneously stained with FITC-labeled anti-CD3 antibody and Human STEAP1 Protein, Twin-Strep,His Tag (Nanodisc) (5e5 cells were stained with 100 μL of 3 μg/mL of Human STEAP1 Protein, Twin-Strep,His Tag), washed and then analyzed with FACS. Both FITC and PE positive signals was used to evaluate the non-specific binding activity to human CD3+ cells (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

A transmembrane metalloreductase highly overexpressed in prostate cancer with minimal normal tissue distribution. It facilitates cellular iron and copper reduction. Its tumor-selective profile makes it a compelling target for antibody-drug conjugates and T-cell engagers in metastatic prostate cancer.

Recent Advances

 
Drug Development Progress
  • English Name:

    Six-transmembrane epithelial antigen of the prostate 1

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    7 Details

  • Highest Development Stage:

    Phase 3 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland